Tipepidine hydrochloride is a non-narcotic antitussive agent with antidepressant-like effects; it reversibly inhibits dopamine D2 receptor-mediated GIRK currents (IC50 = 7.0 μM), leading to activation of ventral tegmental area (VTA) dopamine neurons; it significantly reduces immobility time in the forced swimming test in ACTH-treated rats and increases extracellular dopamine levels in the nucleus accumbens (NAc).